MDPCP

Last updated
MDPCP
MDPCP structure.png
Identifiers
CAS Number
PubChem CID
Chemical and physical data
Formula C18H25NO2
Molar mass 287.403 g·mol−1
3D model (JSmol)
  • C1CCC(CC1)(N1CCCCC1)c1ccc2c(c1)OCO2
  • InChI=1S/C18H25NO2/c1-3-9-18(10-4-1,19-11-5-2-6-12-19)15-7-8-16-17(13-15)21-14-20-16/h7-8,13H,1-6,9-12,14H2
  • Key:ANUGFLCSICVCSB-UHFFFAOYSA-N

Methylenedioxyphencyclidine (3',4'-MD-PCP, MDPCP) is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, with similar effects to related drugs such as 3-MeO-PCP and 4-MeO-PCP. [1] [2]

Contents

Chemical Properties

MDPCP has the molecular formula C18H25NO2 and a molar mass of 287.403 g·mol−1. Its structural characteristics include a methylenedioxy functional group attached to the phenyl ring, a hallmark of several psychoactive substances within this category.

Pharmacology and Effects

As a dissociative drug, MDPCP exerts its effects primarily through antagonism of the NMDA receptor, resulting in altered sensory perceptions and dissociative states. The drug's subjective effects are reported to be similar to those of related arylcyclohexylamine derivatives.

Given its status as a novel psychoactive substance, MDPCP may be subject to varying degrees of legal control across different jurisdictions, often falling under generic legislation targeting arylcyclohexylamine derivatives or dissociative substances.

See also

References

  1. Wallach JV (2014). Structure activity relationship (SAR) studies of arylcycloalkylamines as N-methyl-D-aspartate receptor antagonists (Ph.D. thesis). University of the Sciences in Philadelphia. 3690548.
  2. Wallach J, Brandt SD (2018). "Phencyclidine-Based New Psychoactive Substances". New Psychoactive Substances. Handbook of Experimental Pharmacology. Vol. 252. pp. 261–303. doi:10.1007/164_2018_124. ISBN   978-3-030-10560-0. PMID   30105474.